| MENU |
|
|
|
VIGEL for Women
An Exciting Sexual Gel that
Increases Feminine Sexual Excitement and Pleasure and Enhances Female Sexual Arousal &
Satisfaction
The Orgasm in a Bottle - Why
Should Men Have All the Fun!
| VIGEL is a nonprescription, topical gel that is applied directly to the clitoral area and dramatically increases feminine sexual arousal. The hottest thing for women since Viagra for men! |
| VIGEL contains special ingredients including Menthol and the amino acid L-Arginine. The Menthol instantly creates a delightful tingling sensation. The L-Arginine dramatically enhances circulation and sensitivity in the clitoral area. |
| VIGEL IS A SAFE TOPICAL GEL
CREAM THAT INCREASES FEMININE SEXUAL EXCITEMENT AND PLEASURE Vigel is a wonderful sensation that increases femine sexual excitement, satisfaction and sexual pleasure. Vigel also increases the frequency and intensity of a woman's orgasms. |
VIGEL and the Nobel Prize in Medicine
The 1998 Nobel Prize for Medicine and Physiology was
awarded for the discovery of the Nitric Oxide Pathway. Nitric Oxide is the basis for
clitoral erection and excitement. L-Arginine causes the production of Nitric Oxide which
in turn improves clitoral circulation and thus leads to increased physical pleasure even
for those women who have already experienced a loss of sexual desire.
Recent double-blind, placebo-controlled, clinical studies suggest that L-Arginine, as
found in VIGEL, dramatically improves female sex drive and sexual relations,
frequency of orgasms and clitoral sensitivity to stimulation.
VIGEL is a sterile, pharmaceutical grade product manufactured to the
strictest laboratory specifications and is guaranteed to improve your sexual excitement or
your money back!
VIGEL - BENEFITS AND PLEASURES
Over 46% of the women in America experience little or no sexual satisfaction from clitoral orgasm and only 25% achieve orgasm with intercourse. In fact, countless numbers of women, between the ages of 18 and 80, do not even know what an orgasm is or how it is achieved. Whether you are multi-orgasmic or are among the 46% of women who are sexually frustrated, every woman who desires maximum sexual fulfillment, greater intimacy, and enhanced relationships stands to benefit from regular use of VIGEL Potential Benefits of This Amazing New Product| An Womans Topical Gel Stimulating Aphrodisiac | Enhance Female Arousal and Sexual Excitement |
| Increased Sexual Endurance and Pleasure | Improvement of Female Clitoral Sensitivity |
| Quick Results No Pills or waiting for months | Helps dispel feelings of depression resulting from lack of sexual fulfillment Not anymore with VIGEL |
| 100% Safe and Natural Satisfaction Guaranteed |
VIGEL is the leading feminine sexual enhancement product on the market. VIGEL is advertised in such national magazines as Glamour, Self and Cosmopolitan.
Clinical research trials based on the 1998 Nobel Prize Medicine trials point to the fact that the L-Arginine in VIGEL causes the production of Nitric Oxide which in turn improves clitoral circulation and sensitivity. This activation process is the entire basis for clitoral arousal, female climax and frequency of orgasm.VIGEL is meant for all women, from those who experience a loss of sexual desire to those who wish to become multi-orgasmic to those who wish to enhance their sexual experiences to even higher levels.
VIGEL is a USA made, sterile, pharmaceutical grade product manufactured to the strictest specifications.
Try VIGEL and enhance your sexual experience. Satisfaction is guaranteed or your money back.
VIGEL
- Enhancing Women's Sexuality and Womens Sexual Health
The "Orgasm in a Bottle" Why Should Men Have All the Fun?
VIGEL SCIENTIFIC EVIDENCE - THE SEXUAL RESEARCH
VIGEL has received rave reviews from women who have no sexual dysfunction but appreciate the product nonetheless because it helps them have more intense sexual excitement and frequent orgasms
| VIGEL has demonstrated its true strength in the following double blind studies conducted on post-menopausal and sexually dysfunctional women. These groups also included women in general, who were experiencing inadequate, or unsatisfactory orgasms or inadequate frequency and/or intensity of orgasmic sexual satisfaction. |
SUMMARIES OF
CLINICAL TRIALS
One study on L-Arginine was conducted on post-menopausal women with Female Sexual Arousal
Disorder or FSAD. The study was designed to determine the effects on vaginal blood flow
and sexual arousal of the Nitric Oxide-precursor L-Arginine (as well as other substances)
on physiological responses to erotic stimuli in post -menopausal women who had experienced
FSAD for at least 6 months.
The study was a randomized, double-blind, placebo-controlled, three-way crossover clinical
trial. Patients were 23 post-menopausal women who met DSM IV criteria for FSAD. The
physiological sexual arousal of the subjects was measured by changes in vaginal pulse
amplitude using a method called Vaginal Photoplethysmography.
The subjects were shown a neutral (non-sexual movie) as well as a film with sexual
content. The degree of each subject's sexual reaction to the neutral as well as to the
sexual movie was measured by the Vaginal Photoplethysmography technology. Subjective
sexual arousal was also gauged by using a Self-Report Questionnaire that was standardized
for all woman involved in the trial.
The results of the Vaginal Photoplethysmography showed a rapid and significant increase in
Vaginal Pulse Amplitude Response (meaning the subject's degree of sexual stimulation) to
the erotic film after the L-Arginine was administered as compared to the placebo group.
The Self-Report Questionnaire yielded similar results. The study theorized that the
mechanism responsible for the increase in sexual arousal was the body's enhanced
production of Nitric Oxide due to the administration of L-Arginine.
The increased Nitric Oxide release caused the women who were given L-Arginine to be
significantly more stimulated by the erotic content of the sexual film as opposed to those
subjects who received the placebo.
The results of another clinical study of L-Arginine were presented at the Ninth Annual
Congress on Women's Health & Gender-Based Medicine in Washington, D.C. The study
indicated significant improvement in women's sexual desire and overall satisfaction. In
this double-blind placebo-controlled study, 93 women, ages 22-73, enrolled as participants
lacking sexual desire.
Of the 93 women involved, 46 received L-Arginine and 47 received a placebo. The
participants used a Female Sexual Function Index Questionnaire to rate their level of
sexual health before starting the study and after taking either a placebo or the
L-Arginine.
At the end of four
weeks, 62 percent of the active group of women reported significantly improved
satisfaction with their overall sex life and 64 percent reported an improvement in their
overall level and intensity of sexual desire...
SEX RESEARCH - VIGEL WORKS!
93 women, ages 22-73, participated in a double-blind, placebo-controlled study to determine the effectiveness of the L-Arginine found in Vigel Sexual Enhancement Cream. 46 received L-Arginine, 47 received a placebo At the end of four weeks, the results follows:
L-ARGININE Research Study |
More Satisfied With Sex Life |
Felt More Sexual Desire |
VIGEL Group |
62% |
64% |
VIGEL for Women - An Exciting Sexual Gel that Increases Feminine Sexual Excitement and Pleasure and Enhances Female Sexual Arousal!
|
These statements have not been evaluated by the Food and Drug Administration. This web site is not intended to diagnose, treat, cure, or prevent any disease. |